Contemporary Compounding





Estradiol 5 mg/g Microemulsion 1/20/2012

This delivery system utilizes a new dosage form.

Nifedipine 160 mg/mL in Pluronic Lecithin Organogel 12/20/2011

This topical preparation may be used to treat Raynaud’s phenomenon and progressive diabetic foot ulcers.

Amikacin 250 mg/mL Injection 11/16/2011

This semisynthetic aminoglycoside antibiotic is presently in short supply.

Oxycodone Hydrochloride 1 mg/mL Oral Liquid 10/19/2011

Product shortages and lack of availability may render it necessary for the pharmacist to compound a suitable alternative.

L-Cysteine Hydrochloride 50 mg/mL Injection 9/20/2011

This formulation can be compounded for use until the manufactured product—recently in short supply—is readily available.

Thioguanine 20 mg/mL Oral Suspension 8/19/2011

A suitable biological safety cabinet should be employed, with excess materials disposed of according to hazardous-drugs standard operating procedures.

Antirheumatic Ointment 7/20/2011

This compound contains six active ingredients with varying mechanisms of pain relief.

Betamethasone Acetate 0.1%, Mupirocin 1%, and Nystatin 1% Nipple Ointment 6/20/2011

This preparation combines an emollient component, which is beneficial for cracked skin, with bacterial action.

Capsaicin 0.05% and Ketamine HCl 2% in Pluronic Lecithin Organogel 5/18/2011

Patients with orofacial neuropathic pain can benefit from this preparation.

Colistimethate Sodium 1.2 mg/mL Ophthalmic Solution 4/20/2011

This formulation should be prepared according to strict aseptic technique by a pharmacist validated in aseptic compounding methods.

Melaleuca Acne Gel 3/18/2011

Tea tree oil, which is used to treat some skin disorders, has fungicidal and bactericidal properties.

Coenzyme Q10 100 mg and Lipoic Acid 100 mg Chewable Troches 2/18/2011


Patients taking cholesterol-lowering drugs may use this preparation supplementally.


Tiagabine Hydrochloride 1 mg/mL Oral Liquid 1/20/2011

This form may be used by patients unable to take the oral solid form of this anticonvulsant.

Terbinafine and Urea Antifungal Cream 12/17/2010

This topical agent may be used for such infections as tinea pedis, tinea cruris, and tinea corporis.

Baclofen 2%, Gabapentin 6%, and Clonidine Hydrochloride 0.1% in Pluronic Lecithin Organogel 11/17/2010

This product warms up as it is smoothed into the skin, which may render it more viscous and rub-resistant.

Albendazole 200 mg/5 mL Oral Suspension 10/20/2010

This formulation is an alternative for patients who are unable to swallow the tablets.

Piroxicam, Methyl Salicylate, Menthol, and Capsaicin Topical Gel 9/20/2010

This formulation provides relief for sore muscles and mild-to-moderate joint pain.

Potassium Citrate 100 mg/mL and Methscopolamine Hydrobromide 0.5 mg/mL Solution 8/19/2010

This updated compound is more uniform and reliable than the alkaline bladder formulation on which it is based. 

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, and Ketoprofen 2% in Pluronic Lecithin Organogel 7/20/2010

Patients with mild-to-moderate neuropathic pain can benefit from treatment with this product.

 

Meperidine Hydrochloride and Promethazine Hydrochloride Capsules 6/17/2010

When a product is discontinued for economic reasons and is no longer available, it still may be prescribed through compounding.
For more articles, please check our archives.
Advertisement